MULTIPLE SCLEROSIS (MS)
Clinical trials for MULTIPLE SCLEROSIS (MS) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help young MS patients?
Disease control Recruiting nowThis study tests whether metformin, a common diabetes drug, can help repair nerve damage in children and young adults (ages 10-25) with multiple sclerosis. Participants take metformin daily for 3 to 9 months, and researchers monitor safety, tolerability, and changes in vision and…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE1, PHASE2 • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Old allergy drug shows promise for repairing MS nerve damage
Disease control Recruiting nowThis study tests whether clemastine fumarate, an old allergy medicine, can help repair the protective coating (myelin) around nerves in people with multiple sclerosis (MS). About 74 adults with relapsing-remitting MS will receive either the drug or a placebo, and advanced MRI sca…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New study seeks best MS treatment for older adults
Disease control Recruiting nowThis study looks at two ways to treat multiple sclerosis (MS) in people who were diagnosed after turning 50. One approach starts with milder drugs and only uses stronger ones if needed, while the other starts with stronger drugs right away. The goal is to see which strategy bette…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called QH103 in 6 people with severe autoimmune diseases like multiple sclerosis and myasthenia gravis that haven't responded to standard treatments. The therapy uses specially engineered immune cells to target and calm the overacti…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Music that matches your heartbeat may ease MS pain
Symptom relief Recruiting nowThis study tests a new approach to managing chronic pain in multiple sclerosis (MS). Participants will receive music therapy or motor imagery training through video calls, with music or sounds timed to their heart rate. The goal is to see if this can lower pain, improve mood, sle…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: NA • Sponsor: Istanbul Bilgi University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Brain scans could predict MS disability years in advance
Knowledge-focused Recruiting nowThis study looks at how special brain scans (MRI and PET) can predict long-term disability in people with multiple sclerosis (MS). Researchers will follow 80 adults who have been in earlier MS studies for at least 8 years. The goal is to find imaging markers that show how the dis…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 17, 2026 05:05 UTC
-
New MRI technique may spot hidden spinal cord lesions in MS patients
Knowledge-focused Recruiting nowThis pilot study aims to see if a new MRI sequence called AMIRA can better detect spinal cord lesions in people with multiple sclerosis (MS). Ten adults with MS will undergo both standard and new MRI scans to compare how many lesions are found and how well doctors agree on the re…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC
-
New protein clue may unlock MS mysteries
Knowledge-focused Recruiting nowThis study aims to understand how a protein called VISTA, which helps control the immune system, behaves in people with multiple sclerosis (MS) compared to healthy individuals. Researchers will collect blood samples from 60 participants at their first MS attack and again after 6 …
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Koç University • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC
-
MS patients test video tool to improve End-of-Life planning
Knowledge-focused Recruiting nowThis study looks at whether a 10-minute video about palliative care can help people with multiple sclerosis (MS) understand their care options and make decisions that match their values. Fifty adults with MS will be split into two groups: one watches the video, the other reads a …
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: NA • Sponsor: Hunter College of City University of New York • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC